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In this issue of Cell Death & Disease, Morselli et al. described
that calorie restriction (CR) and resveratrol activate
autophagythroughsirtuin-1 and, mostimportantly, autophagy
is required for the life extending effect of CR (Figure 1a). This
paper touches upon three hot topics, entering into three
debated ﬁelds. Let us discuss this in a broader context. In
almost all species from yeast to primates, CR increases both
median and maximal lifespan. Still the topic remains highly
controversial. Why? As I recently analyzed, the antiaging
effectofCR rulesoutthemostintuitive theoryofaging(see for
reference, Blagosklonny
1). According to the current dogma,
aging is caused by lifelong accumulation of molecular
damage. This damage is not repaired completely because
energetic resources are limited in the wild.
2 This must predict
thatthe fewer the resources (CR), the less resources couldbe
spend for repair (and the faster aging). Yet we know that CR
slows down aging. To reconcile this fact with the theory, it was
suggested that an organism allocates more resources to ﬁght
aging during famine or CR, in order to live longer and to
reproduce later,
2 even though aging does not limit lifespan in
the wild. This suggestion leads to unfathomable paradoxes,
forcing us to reconsider the origin of aging.
1 In fact, recent
discoveries reveal that aging is genetically regulated.
3 For
example,inhibitionofTOR(targetofrapamyin)oractivationof
sirtuins prolongs lifespan. And CR both deactivates TOR and
activates sirtuins. But here is a second debate: which is
indispensable for prolonged lifespan by CR, inhibiting TOR or
activating sirtuins?
On one hand, it was shown that CR slows down aging
through TOR.
4,5 On the other hand, it was shown that CR and
resveratrol activate sirtuins, thus extending lifespan.
6,7 Let us
start the discussion with TOR. The TOR intracellular signal-
transduction pathway is conserved in eukaryotes from yeast
to mammals.
8 In mammals, TOR (known as mTOR)
integrates signals (nutrients, hormones, growth factors,
stressors) through a complex signaling network. Nutrients
also increase levels of insulin, which additionally activates
mTOR. TOR increases protein synthesis and inhibits auto-
phagy, driving cellular mass growth.
9,10 TOR also activates
cellular functions, ranging from the bone absorption by
osteoclasts and the contractility in smooth muscle cells to
insulin secretion by b-cells of the pancreas and lipoprotein
synthesis in liver.
11 Finally, cellular hyperactivation causes a
feedback signal resistance. For example, mTOR by activating
S6 kinase causes insulin resistance. All these cellular
alterations can be linked to organismal aging and age-related
diseases such as benign and malignant tumors, cardiac
hypertrophy, osteoporosis, metabolic syndrome, athero-
sclerosis, hypertension, neurodegeneration and age-related
macular degeneration.
11 Like in yeast,
5 serum starvation and
rapamycin suppress mammalian cell senescence.
12 Finally,
rapamycin extends lifespan in mice.
13
Similarly, there is a strong case that NAD(þ)-dependent
deacetylases, called sirtuins, such as SIRT1 and Sir2 are
involved in aging and age-related diseases.
6,7 Evidence has
emerged that sirtuins and mTOR are involved in the same
longevity pathway.
14 Importantly, resveratrol, an activator of
sirtuins,antagonizesthemTOR/S6Kpathway.
15,16Therefore,
two notions that CR prolongs lifespan either by activating
sirtuins or by deactivating TOR are complementary: CR
deactivates the mTOR pathway in part by activating SIRT1
(Figure 1b).
In addition, sirtuins and TOR have opposing effects on
autophagy independently from each other. As shown by
Morselli et al. (this issue), sirtuin-1 was not required for
the induction of autophagy by rapamycin. And, vice versa,
sirtuin-1 can deacetylate essential autophagic modulators,
such as ATG5 and ATG7, inducing autophagy. In addition to
independent effects on common targets (such as autophagy),
sirtuins may antagonize the TOR pathway both upstream of
and downstream from mTOR (Figure 1b). Therefore, sirtuins
and the TOR pathway form a complex contrasting network,
with autophagy one of its downstream effectors.
And here is a third debated question: what is the
signiﬁcance of autophagy in longevity. Is autophagy required
for life extension by CR? Would it be sufﬁcient to upregulate
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TOR) in order to live longer? Could lifespan be increased
without activating autophagy? At least for worms and ﬂies, the
answer to the ﬁrst question seems to be yes, whereas the
answer to two other questions is still unclear.
As shown by Kroemer and co-workers (this issue),
resveratrol and dietary restriction only prolonged the lifespan
of autophagy-proﬁcient nematodes, whereas these beneﬁcial
effects on longevity were abolished by the knockdown of the
essential autophagic modulator Beclin-1. Taken together with
similar results in the literature, this indicates that autophagy is
a very signiﬁcant component for life extension. However,
autophagy is such a fundamental cellular function that its
inhibition would shorten lifespan, regardless of its role in
the aging process. This would obfuscate determining its role
in aging.
Although, the induction of autophagy increases lifespan in
Drosophila, Atg1, a gene that stimulates autophagy, also
inhibits the TOR pathway.
17 The activation of autophagy in
turn inhibits TOR.
17 Is autophagy the only longevity mechan-
ism? Although longevity pathways converge on autophagy,
they converge on autophagy through TOR and sirtuins. Other
effects of TOR inhibition may be essential for longevity. From
this point of view, inhibition autophagy is one (but not the only
one) end point of TOR-driven aging (Figure 1b). For example,
rapamycin inhibits polyglutamine aggregation independently
of autophagy by reducing protein synthesis.
18 Inhibition of
translation is sufﬁcient to extend lifespan in Caenorhabditis
elegans (see for reference
9). Although the antiaging effect of
CR can be linked to autophagy,
19 autophagy is not sufﬁcient
for lifespan extension.
19
Roughly speaking, autophagy is a degradation of intra-
cellular components in lysosomes. The lysosomal theory of
aging (or the ‘garbage’ accumulation theory of aging) was
formulated a half century ago. This theory explains some
features of aging such as accumulation of lypofuscin and in
part neurodegenerative diseases. Insufﬁcient autophagy is
linked to some other diseases and conditions.
20 Still
lysosomal insufﬁciency cannot explain other attributes of
aging such as menopause and insulin-resistance, just to
name a few.
There are some other difﬁcult questions faced by lysosomal
theory of aging. Why would autophagy fail in all species from
yeast to man? Is autophagy such a neglected cellular function
that causes aging universally? Is there an inherent problem
with autophagy that could not be solved by nature? Or
perhaps autophagy is one of the ‘tips of the iceberg’ of
something else. This underlying process is neither failure of
maintenance nor random damage but a calorie-dependent
quasi-program, an aimless continuation of the developmental
growth.
1,11 The nutrient-sensing pathways are essential for
growth and development. Their inhibition or knockout is lethal
in early development. This is an example of antagonistic
pleiotropy. The nutrient-sensing and growth promoting net-
work is beneﬁcial and essential early in life but drives aging
later in life. As development and growth are universal features
of life, aging is universal too. But now we can suppress aging
pharmacologically.
Preferably, an antiaging drug should not directly interfere
with autophagy but rather should act upstream (e.g., sirtuins
and TOR), in order to inhibit the cause of aging and all its
manifestations.Imentionrapamycin asanexample. Onemay
argue that TOR-deﬁcient mutant animals have growth and
other defects. But unlike genetic knockout, pharmacological
inhibition of mTOR with rapamycin could be (and should be)
performed in aging individuals, thus avoiding inhibition of
mTOR during growth and development. (Why would we think
aboutpreventionofagingininfants?).Also,thereisnoneedto
inhibit mTOR completely and at low doses rapamycin may
have no side effects, because even at high doses its side
effects are minimal. Upstream activators of autophagy, such
as rapamycin, resveratrol and metformine are well-tolerated
drugs.
21 In contrast, there is no drug that directly activate
autophagy in mammalian cells and even if there were, such a
chemicalmighthavebothon-targetandoff-targetsideeffects.
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